Top Raleigh, NC Pharmaceutical Companies (36)
Don't see your company?
Create a company profile
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. We are powered by technology. Our Global Research Technologies, Medical Devices as a software, and Data Science teams are on the cutting edge of developing and supporting our life-saving medications.
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for pro-innovation/pro-patient policies.
Best Practices provides consulting and advisory services to Pharma, Biotech, Medical Device and other Healthcare companies. We believe that patients and their families deserve great medical outcomes and it is our mission to help healthcare companies in making that possible by providing answers to the simple question: How do other companies do it? "It" can be any strategic issue or need where Best Practice benchmark tools and executive interviews can help companies improve efficiencies and efforts. We believe in the simple yet profound principle that organizations can chart a course to superior performance by studying the best business practices, operating tactics, and winning strategies of other world-class companies. For more information, please email Cameron Tew at [email protected] or call 919-767-9246 to learn more.
Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need. Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients.
Alphanumeric is leading life science and healthcare organizations toward a more efficient future - where patients and providers are met with personalized communication at every stage of their journey. Our teams are driven to improve and enhance interpersonal and patient experiences across industries. We provide more than call centers - we go beyond them to provide top-tier customer service, patient experience support, and HCP engagement that exceed expectations.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
Founded in 1997, Ergomed is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, and Ergomed Clinical Research, a complete, global Phase I-IV clinical development and trial management services with a strong heritage in the development of drugs in rare diseases and oncology. • 1,400+ highly qualified professionals • Global full-service CRO • 25+ years of experience • Therapeutic specialization in oncology • Strong expertise in rare disease trials • Robust clinical safety system • Choice of leading drug safety databases Our key services include: • Clinical Research Services • Pharmacovigilance • Medical Information • Regulatory • Medical Writing • Site Management • Study Physician Support • Biostatistics • Patient Study Support
RxSolutions is a company that specializes in customized pharmaceutical reimbursement programs.
Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization.
Continuous Precision Medicine™ is a leader in the fight against the opioid epidemic.
On paper, we are a technology-driven biopharmaceutical solutions company. But on a daily basis, we make sure patients come first. We do this by providing biopharmaceutical manufacturers with an integrated suite of solutions that enhance patient and provider experiences. And better experiences lead to better outcomes. When TrialCard was founded in 2000, we knew that an all-inclusive enterprise management system was essential for an easily accessible, user-friendly patient experience. We’ve spent the last several years expanding and perfecting our services, that prioritize patients and simplify access to the care they deserve.
At Merz Therapeutics, we seek to address the unique needs of people who suffer from movement disorders, neurological conditions, and other health conditions that severely impact patients’ quality of life. With our patient-centric approach, cutting-edge research and development efforts, highly-scientific medical affairs resources and dedicated commercial teams, we continue the advancement of new and individualized treatment standards, including botulinum toxin. Merz Therapeutics is headquartered in Frankfurt am Main, Germany and is represented in more than 90 countries, with a North America affiliate based in Raleigh, North Carolina. Merz Therapeutics GmbH is part of the Merz Group, a privately held, family-owned company that has dedicated more than 110 years to developing innovations that serve unmet patient and customer needs.
PCI is a pharmaceutical company specializing in calibration and data analysis services.
BioDelivery Sciences is a specialty pharmaceutical company focusing on pain management and addiction medicine.
We’re out to change the course of medical science. Are you ready to rise to the challenge? Premier Research is not about being everything to everyone. Instead, our deep, focused expertise targets the therapeutic areas and indications where today’s biotech and specialty pharma pioneers are doing the most amazing work. We’re 1,500 employees strong and operate in more than 20 countries, delivering unmatched expertise, operational skills, and dedication to meeting customers’ most challenging needs. Join us and meet some of the brightest minds in clinical development today — people who apply their best thinking to every project, recognizing that what they do significantly affects the lives and well-being of customers, patients, physicians, and colleagues. You’ll enjoy great benefits and very flexible working conditions in a company that values your contributions, rewards your achievements, and is committed to helping you reach your full potential. Are you ready to make a real difference and help us transform this exciting industry? Follow our company page for more information about us and the work we do, and check out our current openings for your next career move!
Who We Are Triangle Insights Group is a strategy consulting firm providing guidance on the most critical business issues to leaders in life sciences organizations. The firm’s approach combines deep knowledge of the industry, across therapeutic areas and functional groups, with a dedication to creativity and strong critical thinking. Recommendations from Triangle Insights Group are original, relevant to the industry environment, and supported by rigorous analytics. Our Vision Our goal is ambitious: to redefine how you think about life sciences consultancies. To replace confusion with clarity. To deliver insights and strategies that foster confidence. Through every step of our customized approaches, you’ll benefit from the personal attention of an entire team of accomplished advisors —their collective vision, collaborative approach and total commitment. Our History Triangle Insights Group, established in April 2013, is an entrepreneurial company. The founding partners are experienced strategy consultants whose backgrounds include Campbell Alliance, Mercer, Boston Consulting Group, and Boston Healthcare. In 2022, the firm was acquired by TrialCard.
With local operations in 132 countries, Stiefel is a global leader in the field of dermatology. Stiefel is renowned for its 165-year legacy of innovation in the field of skin health, utilizing a combination of expertise, enthusiasm and imagination to deliver the highest quality, most effective prescription and over-the-counter skin care products available. Stiefel, a GSK company social media channels: Twitter: http://twitter.com/stiefelagskco Facebook: http://www.facebook.com/StiefelGSK Stiefel Laboratories, Inc. was acquired by GlaxoSmithKline in July 2009. The acquisition has created a new world-leading specialist dermatology business. As part of the acquisition, Stiefel Laboratories is now called Stiefel, a GSK company.
MAA Laboratories Inc. is a specialty pharmaceutical company located in the Research Triangle Park region of North Carolina. MAA has developed the NanoCont™ drug development platform as a broadly applicable solution for addressing a variety of drug delivery and development challenges. Our company is dedicated to using the NanoCont™ technology to create advanced medicines that improve patients' lives by addressing unmet clinical needs in a variety of therapeutic areas, including oncology, neurological, and cardiovascular diseases.
Wake Research is an integrated network of premier investigational sites working closely with and meeting the needs of the global biopharmaceutical, biotechnology, medical device, pharmaceutical industry, and clinical research organizations. Wake Research has its proprietary patient database of more than 2 million potential clinical trial participants—men and women, children and adults, across all ethnicities—for all kinds of adaptive and other types of trial designs. Conducting studies since 1984, we have a combined subject database of more than 2 million, and we’re still growing. As of today, our board-certified physicians have completed more than 7,000 successful clinical trials. Clinical trials at our site are always completed on time and with accuracy; we consistently exceed sponsor expectations for integrity, subject enrollment, human protection, and expeditious delivery of accurate evaluable data. Our approach is uncompromising – each study conducted at our site is carefully planned and executed according to regulations with superior quality.
Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.
Work Your Passion. Live Your Purpose.
